Trefoil factor family domain peptides

Virchows Archiv

Volumn 431, Issue 5, 1997, Pages 299-304

  Williams, G R ^a   Wright, N A ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

TFF domain; Trefoil

Indexed keywords

ESTROGEN; GROWTH FACTOR; INTESTINAL TREFOIL FACTOR; MUCIN; TREFOIL PEPTIDE;

BREAST; BREAST CARCINOMA; DIGESTIVE SYSTEM CANCER; EPITHELIUM CELL; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL TRACT; GENETIC CONSERVATION; GYNECOLOGIC CANCER; HORMONAL REGULATION; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; INFLAMMATION; LUNG CARCINOMA; MUCOSA; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; URINARY TRACT CANCER; WOUND HEALING;

ANIMALS; DIGESTIVE SYSTEM; GROWTH SUBSTANCES; HUMANS; IMMUNITY, MUCOSAL; MUCINS; MUSCLE PROTEINS; NEOPLASMS; NEUROPEPTIDES; PEPTIDES; TISSUE DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL; WOUND HEALING;

EID: 0030700206     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050102     Document Type: Review

References (67)

1. Ahnen DA, Gullick W, Wright NA (1991) Multiple growth factor production by the cell lineage induced by mucosal ulceration in Crohn's disease. Gastroenterology 100 (5/2): A512
2. Babyatsky MW, DeBeaumont M, Thim L, Podolsky DK (1996) Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats. Gastroenterology 110: 489-497
3. Bonkhoff H, Stein U, Welter C, Remberger K (1995) Differential expression of the pS2 protein in the human prostate and prostate cancer: association with premalignant changes and neuroendocrine differentiation. Hum Pathol 26: 824-828
4. Cappelletti V, Coradini D, Scanziani E, Benini E, Silvestrini R, Di Fronzo G (1992) Prognostic relevance of pS2 status in association with steroid receptor status and proliferative activity in node-negative breast cancer. Eur J Cancer [A] 28: 1315-1318
5. Cavailles V, Garcia M, Rochefort H (1989) Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells. Mol Endocrinol 3: 552-558
6. Chinery R, Cox HM (1995) Modulation of epidermal growth factor effects on epithelial ion transport by intestinal trefoil factor. Br J Pharmacol 115: 77-80
7. Chinery R, Playford R (1995) Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat. Clin Sci 88: 401-403
8. Chinery R, Williamson J, Poulsom R (1996) The gene encoding human intestinal trefoil factor (TFF3) is located on chromosome 21q22.3 clustered with other members of the trefoil peptide family. Genomics 32: 281-284
9. De A, Brown DC, Gorman MA, Carr M, Sanderson MR, Freemont PS (1994) Crystal structure of a disulfide-linked "trefoil" motif found in a large family of putative growth factors. Proc Natl Acad Sci USA 91: 1084-1088
10. Dignass A, Lynch-Devaney K, Kindon H, Thim L, Podolsky DK (1994) Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J Clin Invest 94: 376-383
11. Foekens JA, Rio M-C, Seguin P, et al (1990) Prediction of relapse and survival in breast cancer patients by pS2 protein status. Cancer Res 50: 3832-3837
12. Gajhede M, Petersen TN, Henriksen A, et al (1993) Pancreatic spasmolytic polypeptide: first three-dimensional structure of a member of the mammalian trefoil family of peptides. Structure 1: 253-262
13. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, et al (1990) Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 265: 15286-15293
14. Giraud AS, Parker LM, Whitehead R (1994) Colon cancer cell lines expressing the MUC2 gene also secrete trefoil peptides. Gastroenterology 106: A810
15. Gumbiner BM (1995) Signal transduction by β catenin. Curr Opin Cell Biol 7: 634-640
16. Hanby AM, Chinery R, Poulsom R, Playford RJ, Pignatelli M (1996) Downregulation of E-cadherin in the reparative epithelium of the human gastrointestinal tract. Am J Pathol 148: 723-729
17. Hauser F, Poulsom R, Chinery R, et al (1993) hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed in the ulcer associated cell lineage and the uterus. Proc Natl Acad Sci USA 90: 6961-6965
18. Henry JA, Nicholson S, Hennessy C, Lennard TW, May FE, Westley BR (1989) Expression of the estrogen-regulated pNR-2 mRNA in human breast cancer: relation to estrogen receptor mRNA levels and response to tamoxifen therapy. Br J Cancer 61: 32-38
19. Henry JA, Bennett MK, Piggott NH, Levett DL, May FE, Westley BR (1991) Expression of the pNR-2/pS2 protein in diverse human epithelial tumours. Br J Cancer 64: 677-682
20. Higashiyama M, Doi O, Kodama K, et al (1994) Prognostic significance of pS2 protein expression in pulmonary adenoearcinoma. Eur J Cancer [A] 30: 792-797
21. Higashiyama M, Doi O, Kodama K, Yokuchi H, Inaji H, Tateishi R (1996) Estimation of serum pS2 protein in patients with lung adenocarcinoma. Anticancer Res 16: 2351-2356
22. Hoosein NM, Thim L, Jørgensen KH, Brattain MG (1989) Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cells. FEBS Lett 247: 303-306
23. Jeffrey GP, Gates PS, Wang TC, Babyatsky MW, Brand SJ (1994) Spasmolytic polypeptide: a trefoil peptide secreted by rat gastric mucous cells. Gastroenterology 106: 336-345
24. Jørgensen KH, Thim L, Jacobsen HE (1982) Pancreatic spasmolytic polypeptide (PSP). I. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas. Regul Pept 3: 207-219
25. Jørgensen KD, Diamant B, Jørgensen KH, Thim L (1982) Pancreatic spasmolytic polypeptide (PSP). III. Pharmacology of a new porcine pancreatic polypeptide with spasmolytic and gastric acid secretion inhibitory effects. Regul Pept 3: 231-243
26. Lacy ER, Morris GP, Cohen MM (1993) Rapid repair of the surface epithelium in human gastric mucosa after acute superficial injury. J Clin Gastroenterol 17 [Suppl 1]: S125-S135
27. Lalani E-N, Williams R, Jayaram Y, Thim L, Wright NA, Stamp GWH (1995) Effect of hSP on growth and proliferation of MCF-7 cells. J Pathol (Lond) 175 [Suppl]: 109A
28. Lefebvre O, Chenard M-P, Massen R, et al (1996) Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274: 259-262
29. Liu D, Chinery R, Wilding J, Gullick WJ, Kmiot W, Pignatelli M (1996) Phosphorylation of beta-catenin and epidermal growth-factor receptor by intestinal trefoil factor. J Pathol (Lond) 179: A10
30. Luqmani Y, Bennett C, Paterson I, et al (1989) Expression of the pS2 gene in normal, benign and neoplastic human stomach. Int J Cancer 44: 806-812
31. Machado JC, Carneiro F, Blin N, Sobrinho-Simoes M (1996) Pattern of pS2 protein expression in premalignant and malignant lesions of gastric mucosa. Eur J Cancer Prev 5: 169-179
32. Machado JC, Carneiro F, Ribeiro P, Blin N, Sobrinho-Simoes M (1996) pS2 protein expression in gastric carcinoma. An immunohistochemical and immunoradiometric study. Eur J Cancer 32: 1585-1590
33. Mashimo H, Wu D-C, Podolsky DK, Fishman MC (1996) Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 274: 262-265
34. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P (1982) Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucl Acids Res 10: 7895-7903
35. McKenzie C, Marchbank T, Playford RJ, Otto W, Thim L, Parsons ME (1997) Pancreatic spasmolytic polypeptide (PSP) protects the gastric mucosa but does not inhibit acid secretion or motility. Am J Physiol (in press) [Gastrointest Liver Physiol] 36: G112-G117
36. Moisan J-P. Mattei M-G, Mandel J-L (1988) Chromosome localization and polymorphism of an oestrogen-inducible gene specifically expressed in some breast cancers. Hum Genet 79: 168-171
37. Moore R, Carlson S, Madara JL (1989) Rapid barrier restitution in an in vitro model of intestinal epithelial injury. Lab Invest 60: 237-244
38. Muller W, Borchard F (1993) pS2 protein in gastric carcinoma and normal gastric mucosa: association with clinicopathological parameters and patient survival, J Pathol (Lond) 171: 263-269
39. Munemitsu S, Albert I, Souza B, Rubinfield B, Polakis P (1995) Regulation of intracellulur β catenin levels by the adenomatous polyposis coli (APC) tumour-suppressor protein. Proc Natl Acad Sci USA 92: 3046-3050
40. Nunez AM, Berry M, Imler JL, Chambon P (1989) The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. EMBO J 8: 823-829
41. Pallud C, Le Dousal V, Pichon M-F, Prud'homme J-F, Hacene K, Milgrom E (1993) Immunohistochemistry of pS2 in normal human breast and in various histological forms of breast tumours. Histopathology 23: 249-256
42. Playford RJ, Marchbank T, Chinery R, et al (1995) Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 108: 108-116
43. Playford RJ, Marchbank T, Goodlad RA, et al (1996) Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad Sci USA 93: 2137-2142
44. Podolsky DK, Lynch-Devaney K, Stow JL, et al (1993) Identification of human intestinal trefoil factor: goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 268: 6694-6702
45. Poulsom R (1997) Molecular aspects of restitution. In: Halter F, Winton D, Wright NA (eds) The gut as a model in cell and molecular biology. Kluwer Falk Symp 94
46. Poulsom R, Wright NA (1993) Trefoil peptides: a newly recognized family of epithelial mucin-associated molecules. Am J Physiol [Gastrointest Liver Physiol] 265[28]: G205-G213
47. Poulsom R, Chinery R, Sarraf C, et al (1992) Trefoil peptide gene expression in intestinal adaptation and renewal. Scand J Gastroenterol 27 [Suppl 192]: 17-28
48. Prud'homme JF, Fridlansky F, Le Cunff M, et al (1985) Cloning of a gene expressed in human breast cancer and regulated by estrogen in MCF-7 cells. DNA 4: 11-21
49. Rio M-C, Bellocq JP, Gairard B, et al (1987) Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc Natl Acad Sci USA 84: 9243-9247
50. Rio M-C, Chenard MP, Wolf C, et al (1991) Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology 100: 375-379
51. Sands BE, Ogata H, Lynch-Devaney K, deBeaumont M, Ezzell RM, Podolsky DK (1995) Molecular cloning of the rat intestinal trefoil factor gene: characterization of an intestinal goblet cell-associated promoter. J Biol Chem 270: 9353-9361
52. Schmitt H, Wundrack I, Beck S, et al (1996) A third P-domain peptide gene (TFF3), human intestinal trefoil factor, maps to 21q22.3. Cytogenet Cell Genet 72: 299-302
53. Seib T, Dooley S, Welter C (1995) Characterization of the genomic structure and the promoter region of the human intestinal trefoil factor. Biochem Biophys Res Commun 214: 195-199
54. Skilton RA, Luqmani YA, McClelland RA, Coombes RC (1989) Characterisation of a messenger RNA selectively expressed in human breast cancer. Br J Cancer 60: 168-175
55. Suemori S, Lynch-Devaney K, Podolsky DK (1991) Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc Natl Acad Sci USA 88: 11017-11021
56. Svanes K, Itoh S, Takeuchi K, Silen W (1982) Restitution of the surface epithelium of the in vitro frog gastric mucosa after damage with hypermolar sodium chloride. Gastroenterology 82: 1409-1426
57. Szabo S, Folkman J, Vattay P, Morales RE, Pinkus GS, Kato K (1994) Accelerated healing of duodenal ulcers by administration of a mutein of basic fibroblast growth factor in rats. Gastroenterology 106: 1106-1111
58. Taupin D, Ooi K, Yeomans N, Giraud A (1996) Conserved expression of intestinal trefoil factor in the human colonic adenoma-carcinoma sequence. Lab Invest 75: 25-32.59
59. Theisinger B, Welter C, Seitz G, et al (1991) Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic polypeptide gene (hSP) in diffuse type of stomach carcinoma. Eur J Cancer 27: 770-773
60. Thim L (1989) A new family of growth factor-like peptides. 'Trefoil' disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins). FEBS Lett 250: 85-90
61. Thim L, Jørgensen KH, Jørgensen KD (1982) Pancreatic spasmolytic polypeptide (PSP). II. Radioimmunological determination of PSP in porcine tissues, plasma and pancreatic juice. Regul Pept 3: 221-230
62. Tomasetto C, Rio M-C, Gautier C, et al (1990) hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J 9: 407-414
63. Tomasetto C, Rockel N, Mattei MG, Fujita R, Rio M-C (1992) The gene encoding the human spasmolytic protein (SML1/hSP) is in 21q22.3, physically linked to the homologous breast cancer marker gene BCEI/pS2. Genomics 13: 1328-1330
64. Welter C, Theisinger B, Seitz G, et al (1992) Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma. Lab Invest 66: 187-192
65. Williams R, Stamp GWH, Gilbert C, Pignatelli M, Lalani E-N (1996) pS2 transfection of murine adenocarcinoma cell line 410.4 enhances dispersed growth pattern in a 3-D collagen gel. J Cell Science 109: 63-71
66. Wright NA, Poulsom R, Stamp G, et al (1993) Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 104: 12-20
67. Wright NA, Poulsom R, Stamp GW, et al (1990) Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol 162: 279-284